Pharma academic research - Indian patent applications published in the month of October 2016

Every week of thousands of patent applications are published in India. The patent applications filed by the pharma academic research institutes in India go un-noticed.

We publish a list of Indian applications published related to pharma academics. This would provide us an idea about the kind of academic research being carried out in these institutes. For details of these patents, please write back to us at pharmaliterati@gmail.com

Invention
Application No
Inventors
Institute
7th October 2016
Lercanidipine polymeric nanoparticles and a composition thereof
1687/CHE/2015A
1) Deshpande Praful Balavant
2) Gurram Arvind Kumar
3) Averineni Ranjith Kumar
4) Reddy M. Sreenivasa
5) Udupa Nayanabhirama
Manipal college of Pharmaceutical sciences, Manipal University, Karnataka.
14th October 2016
Isoxazoyl styrylchromones as selective estrogen receptor modulators
978/DEL/2015A
1) Swati Kaushik
2) Megha Rikhi
3) Seema Bhatnagar
Amity University, Noida, Uttar Pradesh.
A method for the synthesis of 3-aminoalkyl-2-styryl chromone derivatives for anticancer and antioxidant activity
979/DEL/2015A
1) Swati Kaushik
2) Megha Rikhi
3) Seema Bhatnagar
Amity University, Noida, Uttar Pradesh.
Floating tablet formulation of domperidone
1010/DEL/2015 A
1) Kumar Sanjeev
2) Dr Arora Sandeep
3) Singh Inderbir
4) Malviya Sarvesh
Chitkara University Chandigarh-Patiala National Highway (Dist.) Patiala Punjab.
A novel antioxidant sugar free herbal composition lozenges and method of preparation thereof
1017/DEL/2015A
1) Parish Aggarwal
2) Rajinder Kumar Gupta
3) Pratibha Nand
Guru Gobind Singh Indraprastha University, New Delhi
A novel aromatic herbal composition and method of preparation thereof
1016/DEL/2015A
1) Parul Namdev
2) Rajinder Kumar Gupta

Guru Gobind Singh Indraprastha University, New Delhi
21st October 2016
Metallic nanoparticle alone and/or in combination as novel agent for the treatment of uncontrolled electric conductance related disorders and/or seizure, epilepsy & convulsions
2091/DEL/2015A
1) MD Noushad Javed
2) MD Sabir Alam
3) Faheem Hyder Pottoo
Dept of Pharmaceutics, Faculty of Pharmacy, Jamia Hamdard, New Delhi.
28th October 2016
Diethyl (substituted phenyl/heteryl) (2-(2-oxoindolin-3ylidene) hydrazinyl)methyl phosphonate compounds as anticancer agents
201621035782A
1) Anna Pratima Ganpatrao Nikalje
 2) Shailee Vijay Tiwari
3) Rekha Iaranna Gajare
Department of Pharmaceutical Chemistry, Y. B. Chavan college Of Pharmacy, Auragnabad, Maharashtra
A novel bioconjugate drug for targeted treatment of cancer and cancer stem cells
1112/DEL/2015A
1) Dr. BC Das
2) Dr. Seema Bhatnagar
Amity University, Noida, Uttar Pradesh.

Comments

Popular posts from this blog

China-India joint summit discusses bilateral trade to improve pharma industry

Webinar on ‘OPPORTUNITY TO COMMERCIALIZE HERBAL RESEARCH’

WhatsApp Group for Pharma Literati